Pathological mechanisms in progressive multiple sclerosis

Lassmann, 2007, The immunopathology of multiple sclerosis: an overview, Brain Pathol, 17, 210, 10.1111/j.1750-3639.2007.00064.x Lublin, 1996, Defining the clinical course of multiple sclerosis: results of an international survey, Neurology, 46, 907, 10.1212/WNL.46.4.907 Marburg, 1906, Die sogenannte “akute Multiple Sklerose”, Jahrb Psychiatrie, 27, 211 Wiendl, 2009, Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes, Neurology, 72, 1008, 10.1212/01.wnl.0000344417.42972.54 Gourraud, 2012, The genetics of multiple sclerosis: an up-to-date review, Immunol Rev, 248, 87, 10.1111/j.1600-065X.2012.01134.x Ascherio, 2007, Environmental risk factors for multiple sclerosis. Part I: the role of infection, Ann Neurol, 61, 288, 10.1002/ana.21117 Hohlfeld, 2004, Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines, Proc Natl Acad Sci USA, 101, 14599, 10.1073/pnas.0404874101 Coles, 2013, Alemtuzumab therapy for multiple sclerosis, Neurotherapeutics, 10, 29, 10.1007/s13311-012-0159-0 Trapp, 2008, Multiple sclerosis: an immune or neurodegenerative disorder?, Annu Rev Neurosci, 31, 247, 10.1146/annurev.neuro.30.051606.094313 Schuh, 2014, Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models, Acta Neuropathol, 128, 247, 10.1007/s00401-014-1263-5 Sawcer, 2011, Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, Nature, 476, 214, 10.1038/nature10251 Frischer, 2009, The relation between inflammation and neurodegeneration in multiple sclerosis brains, Brain, 132, 1175, 10.1093/brain/awp070 Obermeier, 2011, Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin, J Neuroimmunol, 233, 245, 10.1016/j.jneuroim.2011.01.010 Skulina, 2004, Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood, Proc Natl Acad Sci USA, 101, 2428, 10.1073/pnas.0308689100 Fischer, 2013, Disease-specific molecular events in cortical multiple sclerosis lesions, Brain, 136, 1799, 10.1093/brain/awt110 Fischer, 2012, NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury, Brain, 135, 886, 10.1093/brain/aws012 Smith, 2014, The human side of microglia, Trends Neurosci, 37, 125, 10.1016/j.tins.2013.12.001 Mahad, 2008, Mitochondrial defects in acute multiple sclerosis lesions, Brain, 131, 1722, 10.1093/brain/awn105 Campbell, 2011, Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis, Ann Neurol, 69, 481, 10.1002/ana.22109 Davies, 2013, Neurological deficits caused by tissue hypoxia in neuroinflammatory disease, Ann Neurol, 74, 815, 10.1002/ana.24006 Brownell, 1962, The distribution of plaques in the cerebrum in multiple sclerosis, J Neurol Neurosurg Psychiatry, 25, 315, 10.1136/jnnp.25.4.315 Holland, 2012, The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis, J Neuroimaging, 22, 129, 10.1111/j.1552-6569.2011.00585.x Hallgren, 1958, The effect of age on the non-haemin iron in the human brain, J Neurochem, 3, 41, 10.1111/j.1471-4159.1958.tb12607.x Hametner, 2013, Iron and neurodegeneration in the multiple sclerosis brain, Ann Neurol, 74, 848, 10.1002/ana.23974 Lansley, 2013, Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability, Neurosci Biobehav Rev, 37, 819, 10.1016/j.neubiorev.2013.03.006 Mycko, 2012, Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes, J Neurosci Res, 90, 1941, 10.1002/jnr.23079 Graumann, 2003, Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult, Brain Pathol, 13, 554, 10.1111/j.1750-3639.2003.tb00485.x Cunnea, 2011, Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis, Mult Scler, 17, 808, 10.1177/1352458511399114 Stys, 2005, General mechanisms of axonal damage and its prevention, J Neurol Sci, 233, 3, 10.1016/j.jns.2005.03.031 Vergo, 2011, Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model, Brain, 134, 571, 10.1093/brain/awq337 di Nuzzo, 2014, Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis, Drug Des Devel Ther, 8, 555 de Vries, 2008, Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?, Free Radic Biol Med, 45, 1375, 10.1016/j.freeradbiomed.2008.09.001 Waxman, 2008, Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status, Nat Clin Pract Neurol, 4, 159, 10.1038/ncpneuro0735 Bermel, 2006, The measurement and clinical relevance of brain atrophy in multiple sclerosis, Lancet Neurol, 5, 158, 10.1016/S1474-4422(06)70349-0 Kutzelnigg, 2005, Cortical demyelination and diffuse white matter injury in multiple sclerosis, Brain, 128, 2705, 10.1093/brain/awh641 Ferguson, 1997, Axonal damage in acute multiple sclerosis lesions, Brain, 120, 393, 10.1093/brain/120.3.393 Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N Engl J Med, 338, 278, 10.1056/NEJM199801293380502 Bjartmar, 2000, Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients, Ann Neurol, 48, 893, 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B Bjartmar, 2003, Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease, J Neurol Sci, 206, 165, 10.1016/S0022-510X(02)00069-2 Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am J Pathol, 157, 267, 10.1016/S0002-9440(10)64537-3 Wujek, 2002, Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis, J Neuropathol Exp Neurol, 61, 23, 10.1093/jnen/61.1.23 Mews, 1998, Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions, Mult Scler, 4, 55, 10.1177/135245859800400203 Peterson, 2001, Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions, Ann Neurol, 50, 389, 10.1002/ana.1123 Calabrese, 2009, Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis, Arch Neurol, 66, 1144, 10.1001/archneurol.2009.174 Nielsen, 2013, Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS, Neurology, 81, 641, 10.1212/WNL.0b013e3182a08ce8 Chang, 2012, Cortical remyelination: a new target for repair therapies in multiple sclerosis, Ann Neurol, 72, 918, 10.1002/ana.23693 Lucchinetti, 2011, Inflammatory cortical demyelination in early multiple sclerosis, N Engl J Med, 365, 2188, 10.1056/NEJMoa1100648 Bø, 2003, Subpial demyelination in the cerebral cortex of multiple sclerosis patients, J Neuropathol Exp Neurol, 62, 723, 10.1093/jnen/62.7.723 Moll, 2008, Cortical demyelination in PML and MS: Similarities and differences, Neurology, 70, 336, 10.1212/01.wnl.0000284601.54436.e4 Choi, 2012, Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis, Brain, 135, 2925, 10.1093/brain/aws189 Howell, 2011, Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis, Brain, 134, 2755, 10.1093/brain/awr182 Wegner, 2006, Neocortical neuronal, synaptic, and glial loss in multiple sclerosis, Neurology, 67, 960, 10.1212/01.wnl.0000237551.26858.39 Kutzelnigg, 2007, Widespread demyelination in the cerebellar cortex in multiple sclerosis, Brain Pathol, 17, 38, 10.1111/j.1750-3639.2006.00041.x Geurts, 2007, Extensive hippocampal demyelination in multiple sclerosis, J Neuropathol Exp Neurol, 66, 819, 10.1097/nen.0b013e3181461f54 Vercellino, 2009, Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter, J Neuropathol Exp Neurol, 68, 489, 10.1097/NEN.0b013e3181a19a5a Dutta, 2011, Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients, Ann Neurol, 69, 445, 10.1002/ana.22337 Dutta, 2013, Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors, Ann Neurol, 73, 637, 10.1002/ana.23860 Evangelou, 2005, Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions, Brain, 128, 29, 10.1093/brain/awh323 De Stefano, 2003, Evidence of early cortical atrophy in MS: relevance to white matter changes and disability, Neurology, 60, 1157, 10.1212/01.WNL.0000055926.69643.03 Androdias, 2010, Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords, Ann Neurol, 68, 465, 10.1002/ana.22054 Huynh, 2014, Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains, Nat Neurosci, 17, 121, 10.1038/nn.3588 Franklin, 2008, Remyelination in the CNS: from biology to therapy, Nat Rev Neurosci, 9, 839, 10.1038/nrn2480 Patrikios, 2006, Remyelination is extensive in a subset of multiple sclerosis patients, Brain, 129, 3165, 10.1093/brain/awl217 Albert, 2007, Extensive cortical remyelination in patients with chronic multiple sclerosis, Brain Pathol, 17, 129, 10.1111/j.1750-3639.2006.00043.x Bramow, 2010, Demyelination versus remyelination in progressive multiple sclerosis, Brain, 133, 2983, 10.1093/brain/awq250 Prineas, 1993, Multiple sclerosis. pathology of recurrent lesions, Brain, 116, 681, 10.1093/brain/116.3.681 Rodgers, 2013, Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis, Discov Med, 16, 53 Storch, 1998, Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology, Brain Pathol, 8, 681, 10.1111/j.1750-3639.1998.tb00194.x Merkler, 2006, A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination, Brain, 129, 1972, 10.1093/brain/awl135 Pomeroy, 2005, Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis, Brain, 128, 2713, 10.1093/brain/awh626 Beecham, 2013, Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis, Nat Genet, 45, 1353, 10.1038/ng.2770 Hochmeister, 2006, Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis, J Neuropathol Exp Neurol, 65, 855, 10.1097/01.jnen.0000235119.52311.16 Serafini, 2004, Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis, Brain Pathol, 14, 164, 10.1111/j.1750-3639.2004.tb00049.x Magliozzi, 2007, Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology, Brain, 130, 1089, 10.1093/brain/awm038 Meinl, 2006, B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation, Ann Neurol, 59, 880, 10.1002/ana.20890 Engelhardt, 2005, The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms, Trends Immunol, 26, 485, 10.1016/j.it.2005.07.004 Ransohoff, 2007, Chemokines and chemokine receptors: multipurpose players in neuroinflammation, Int Rev Neurobiol, 82, 187, 10.1016/S0074-7742(07)82010-1 Mycko, 2003, cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity, Brain, 126, 1048, 10.1093/brain/awg107 Na, 2008, Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system, Brain, 131, 2353, 10.1093/brain/awn148 Saxena, 2008, Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes, J Immunol, 181, 1617, 10.4049/jimmunol.181.3.1617 Linington, 1988, Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein, Am J Pathol, 130, 443 Felts, 2005, Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide, Brain, 128, 1649, 10.1093/brain/awh516 Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann Neurol, 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q Prineas, 2001, Immunopathology of secondary-progressive multiple sclerosis, Ann Neurol, 50, 646, 10.1002/ana.1255 Gray, 2008, Elevated myeloperoxidase activity in white matter in multiple sclerosis, Neurosci Lett, 444, 195, 10.1016/j.neulet.2008.08.035 Czeh, 2011, The yin and yang of microglia, Dev Neurosci, 33, 199, 10.1159/000328989 Vogel, 2013, Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status, J Neuroinflammation, 10, 35, 10.1186/1742-2094-10-35 Perry, 2010, Microglia in neurodegenerative disease, Nat Rev Neurol, 6, 193, 10.1038/nrneurol.2010.17 Kolasinski, 2012, A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology, Brain, 135, 2938, 10.1093/brain/aws242 Ohno, 2011, Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier, J Neurosci, 31, 7249, 10.1523/JNEUROSCI.0095-11.2011 Larsson, 2010, Somatic mitochondrial DNA mutations in mammalian aging, Annu Rev Biochem, 79, 683, 10.1146/annurev-biochem-060408-093701 Ohno, 2014, Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons, Proc Natl Acad Sci USA, 111, 9953, 10.1073/pnas.1401155111 Mahad, 2009, Mitochondrial changes within axons in multiple sclerosis, Brain, 132, 1161, 10.1093/brain/awp046 Witte, 2009, Enhanced number and activity of mitochondria in multiple sclerosis lesions, J Pathol, 219, 193, 10.1002/path.2582 Kiryu-Seo, 2010, Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport, J Neurosci, 30, 6658, 10.1523/JNEUROSCI.5265-09.2010 Andrews, 2006, Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse, J Neurosci Res, 83, 1533, 10.1002/jnr.20842 Zambonin, 2011, Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis, Brain, 134, 1901, 10.1093/brain/awr110 Kang, 2008, Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation, Cell, 132, 137, 10.1016/j.cell.2007.11.024 Dutta, 2006, Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients, Ann Neurol, 59, 478, 10.1002/ana.20736 Witte, 2013, Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex, Acta Neuropathol, 125, 231, 10.1007/s00401-012-1052-y Hares, 2013, Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis, Mult Scler Harris, 2012, Control of autophagy as a therapy for neurodegenerative disease, Nat Rev Neurol, 8, 108, 10.1038/nrneurol.2011.200 Stromillo, 2013, Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome, Neurology, 80, 2090, 10.1212/WNL.0b013e318295d707 Narayanan, 2001, Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b, J Neurol, 248, 979, 10.1007/s004150170052 Murphy, 2009, How mitochondria produce reactive oxygen species, Biochem J, 417, 1, 10.1042/BJ20081386 Trapp, 2009, Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis, Lancet Neurol, 8, 280, 10.1016/S1474-4422(09)70043-2 Connor, 2013, Iron and glia, 586 Bagnato, 2011, Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla, Brain, 134, 3602, 10.1093/brain/awr278 Mehta, 2013, Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions, PLoS One, 8, e57573, 10.1371/journal.pone.0057573 Pitt, 2010, Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging, Arch Neurol, 67, 812, 10.1001/archneurol.2010.148 Stahnke, 2007, Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders, J Mol Neurosci, 32, 25, 10.1007/s12031-007-0005-8 van Horssen, 2006, NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions, Free Radic Biol Med, 41, 311, 10.1016/j.freeradbiomed.2006.04.013 van Horssen, 2008, Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression, Free Radic Biol Med, 45, 1729, 10.1016/j.freeradbiomed.2008.09.023 McMahon, 2012, Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis, Mult Scler, 18, 1437, 10.1177/1352458512438455 Veto, 2010, Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death, Brain, 133, 822, 10.1093/brain/awp337 Kornek, 2001, Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis, Brain, 124, 1114, 10.1093/brain/124.6.1114 Werner, 2001, Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage, Ann Neurol, 50, 169, 10.1002/ana.1077